First Time Loading...

New Horizon Health Ltd
HKEX:6606

Watchlist Manager
New Horizon Health Ltd Logo
New Horizon Health Ltd
HKEX:6606
Watchlist
Price: 14.14 HKD Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
New Horizon Health Ltd

Wall Street analysts forecast New Horizon Health Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for New Horizon Health Ltd is 46.53 HKD with a low forecast of 22.22 HKD and a high forecast of 60.33 HKD.

Lowest Forecast
Wall Street Target
22.22 HKD
57% Upside
Average Forecast
Wall Street Target
46.53 HKD
229% Upside
Highest Forecast
Wall Street Target
60.33 HKD
327% Upside
Lowest
Price Target
22.22 HKD
57% Upside
Average
Price Target
46.53 HKD
229% Upside
Highest
Price Target
60.33 HKD
327% Upside
New Horizon Health Ltd Competitors:
Price Targets
DGX
Quest Diagnostics Inc
9% Upside
6HL0
R1 RCM Holdco Inc
32% Upside
T
TALK
Talkspace Inc
52% Upside
ENZ
Enzo Biochem Inc
405% Upside
DGX
Quest Diagnostics Inc
9% Upside
6HL0
R1 RCM Holdco Inc
32% Upside
T
TALK
Talkspace Inc
52% Upside
ENZ
Enzo Biochem Inc
405% Upside
VMD
Viemed Healthcare Inc
78% Upside
SHL
Sonic Healthcare Ltd
19% Upside
4694
BML Inc
9% Upside
CHE
Chemed Corp
21% Upside

Revenue
Forecast

Revenue Estimate
New Horizon Health Ltd

For the last 3 years the compound annual growth rate for New Horizon Health Ltd's revenue is 136%. The projected CAGR for the next 4 years is 49%.

136%
Past Growth
49%
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
New Horizon Health Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
New Horizon Health Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is New Horizon Health Ltd's stock price target?
Price Target
46.53 HKD

According to Wall Street analysts, the average 1-year price target for New Horizon Health Ltd is 46.53 HKD with a low forecast of 22.22 HKD and a high forecast of 60.33 HKD.

What is New Horizon Health Ltd's Revenue forecast?
Projected CAGR
49%

For the last 3 years the compound annual growth rate for New Horizon Health Ltd's revenue is 136%. The projected CAGR for the next 4 years is 49%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.